Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ann Pharmacother ; 57(12): 1361-1366, 2023 12.
Article in English | MEDLINE | ID: mdl-37021360

ABSTRACT

BACKGROUND: Diabetic ketoacidosis (DKA) is a serious acute complication of both type 1 and type 2 diabetes that requires prompt management. Limited data exist supporting the use of a 2-bag DKA protocol in adult patients across all levels of care. OBJECTIVE: To evaluate the efficacy and safety of a 2-bag DKA protocol in comparison with a traditional DKA management strategy. METHODS: Retrospective review of patients admitted with DKA between January 1, 2021, and February 28, 2022, at a single center. Patients were separated into 2 cohorts, traditional or 2-bag. The primary outcome was time to anion gap closure and/or beta-hydroxybutyrate normalization. Secondary outcomes include length of hospitalization, insulin infusion time, and hypoglycemic events. RESULTS: One hundred forty-three patients had a DKA order set initiated during their admission, 59 in the traditional cohort and 84 in the 2-bag cohort. Mean time to anion gap closure was shorter in the 2-bag cohort (12.7 vs 16.9 hours; P = 0.005) and beta-hydroxybutyrate normalization (15.6 vs 25.6 hours; P = 0.026). No difference in hospital length of stay (4 vs 6 days; P = 0.113), duration of insulin infusion (41.6 vs 40.6 hours; P = 0.455), or rates of hypoglycemia (6 vs 4; P = 0.872) was seen. CONCLUSION AND RELEVANCE: Implementation of a 2-bag DKA protocol in the inpatient setting was associated with a shorter time to anion gap closure and beta-hydroxybutyrate normalization. These findings support the option of expansion of a 2-bag DKA protocol to adult patients across all levels of care irrespective of the admission diagnosis.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Ketoacidosis , Adult , Humans , Diabetes Mellitus, Type 2/complications , 3-Hydroxybutyric Acid , Hypoglycemic Agents/adverse effects , Insulin , Retrospective Studies
2.
Air Med J ; 42(4): 259-262, 2023.
Article in English | MEDLINE | ID: mdl-37356886

ABSTRACT

OBJECTIVE: Current analgesia recommendations in the prehospital setting are not specific to critical care transport. Variation exists in the recommended agent and dosing strategies. Furthermore, there is a paucity of literature evaluating benzodiazepine and opiate coadministration, which may place patients at risk for respiratory decompensation. METHODS: This was a retrospective chart review of nonintubated adult critical care transport patients between July 1, 2020, and July 1, 2022, who received fentanyl or ketamine during transport. The primary outcome was the proportion of patients oversedated. The secondary outcomes were characterization of analgesic medication use during transport, the percentage of patients coadministered benzodiazepines, naloxone administration, and escalation of respiratory intervention. RESULTS: Three hundred seventy-six patients were administered fentanyl or ketamine during transport. Eleven patients were oversedated. Three hundred twenty-four patients received fentanyl monotherapy, and 52 received combination therapy. Patients who received benzodiazepines had higher odds of oversedation (odds ratio = 5.75; 95% confidence interval, 1.6-20.7). Two hundred thirty-six patients required an escalation in respiratory support, most commonly an increase from room air to nasal cannula. No patients had naloxone administered. CONCLUSION: The rate of oversedation of nonintubated adult critical care transport patients receiving fentanyl or ketamine is low. Coadministration of benzodiazepines increases the risk of oversedation.


Subject(s)
Analgesia , Ketamine , Adult , Humans , Ketamine/therapeutic use , Retrospective Studies , Pain/drug therapy , Fentanyl/therapeutic use , Critical Care , Benzodiazepines/therapeutic use , Naloxone/therapeutic use
3.
Aust Fam Physician ; 38(5): 311-4, 2009 May.
Article in English | MEDLINE | ID: mdl-19458801

ABSTRACT

BACKGROUND: Chalazia, or meibomian cysts, are often seen in general practice. While most can be resolved with a minor operation in a designated procedure room, there is a lack of published literature on the details of the incision and curettage used to treat this condition. OBJECTIVE: This article outlines the management and treatment of chalazia in the general practice setting. DISCUSSION: Chalazia are a common cause of morbidity in people of all ages. Treatment, which is based on clinical diagnosis, can involve conservative management, intralesional steroid injection, or incision and curettage.


Subject(s)
Chalazion/drug therapy , Chalazion/surgery , Family Practice/methods , Chalazion/prevention & control , Curettage/methods , Glucocorticoids/administration & dosage , Humans , Injections, Intralesional/methods , Secondary Prevention , Triamcinolone/administration & dosage
4.
J AAPOS ; 14(3): 274-6, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20603063

ABSTRACT

We report a case of microphthalmia, inferior adherent leukoma, and optic nerve hypoplasia in an infant whose mother underwent biliopancreatic diversion surgery for obesity 7 years before his birth. The pregnancy was complicated by severe, maternal hypovitaminosis A despite oral supplementation. The infant was found to have undetectable serum vitamin A levels in the perinatal period. At 8 weeks of age, the infant underwent sector iridectomies. At 9 months of age, electroretinography suggested rod dysfunction. His visual performance is poor.


Subject(s)
Eye Abnormalities/etiology , Gastric Bypass/adverse effects , Obesity, Morbid/surgery , Prenatal Exposure Delayed Effects/etiology , Vitamin A Deficiency/complications , Female , Humans , Infant , Infant, Newborn , Male , Night Blindness/etiology , Pregnancy , Pregnancy Complications , Vitamin A Deficiency/etiology
SELECTION OF CITATIONS
SEARCH DETAIL